CRISPR Therapeutics AG Revenue 2015-2025 | CRSP
- CRISPR Therapeutics AG annual revenue for 2024 was $0.037B, a 89.95% decline from 2023.
- CRISPR Therapeutics AG annual revenue for 2023 was $0.371B, a 30885.48% increase from 2022.
- CRISPR Therapeutics AG annual revenue for 2022 was $0.001B, a 99.87% decline from 2021.